drugset / Trial / NCT00052169
Therapy With Docetaxel and ZD1839 for Patients Who Have Advanced Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to learn how breast cancer tumors respond to treatment combining the drugs docetaxel and ZD1839.
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2006-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |
| Subject | Gefitinib | Small molecule | 250 mg | Oral |